Home›Trial›NCT07402915

🔬NCT07402915Phase 1RECRUITING

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study Summary

The purpose of this study is to assess the effect of itraconazole on the pharmacokinetics (PK) of AZ14170132.

Conditions

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal

Interventions / Drugs

AZD5335 Itraconazole

View on ClinicalTrials.gov ↗

Sponsor

Oncology/Respiratory

Study Details

Enrollment24 participants

Primary Completion—

Lead SponsorAstraZeneca

Data Retrieved2026-04-11 02:55:19.909994+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.